The Programme
last update: 28th Mar. 2022
Please note that the programme is subject to change, and will be updated continuously.
All speakers’ lectures will be recorded and available on-demand for a period of 3 months following the actual days of the Conference. Live Broadcast sessions will include live Q&A sections whereby speakers and convenors will be invited to attend the end of their sessions live, to take questions from the participants.
All times are in Central European Time (CEST, UTC+2), Paris, Berlin, Rome, Warsaw. Find the current time for any location or time zone on Time.is!
Day 1
Wednesday
30 March 2022
7:00-8:00 am CEST
Teaching session
Chairs: Prof. Bo Norrving, Prof. Valery Feigin
07:00 Meet the Immediate Past Editor of European Stroke Journal – Prof. Bo Norrving – Sweden
07:20 Meet the Editor of Neuroepidemiology – Prof. Valery Feigin – New Zealand
07:40 Discussion – Q&A
8:00-9:40 am CEST
Plenary session 1: Neurological disorders and COVID-19
Chairs: M.Sc. Erica Westenberg, Prof. Tissa Wijeratne
08:00 Global COVID-19 Neuro Research Coalition – M.Sc. Erica Westenberg – Germany
08:10 Telemedicine in Neurology since the COVID-19 pandemic – Prof. Maurice Giroud – France
08:22 Neurological rehabilitation during the COVID-19 pandemic: What changes and what have we learnt – Prof. Dorcas Gandhi – India
08:50 Post Covid-19 Neurological Syndrome – status and future perspective – Prof. Tissa Wijeratne – Australia
09:05 Telerehabilitation for Neurological care- how real is the impact across the world- HIC versus LMIC perspectives – Prof. Dorcas Gandhi – India
09:34 Primary stroke and cardiovascular disease prevention strategy needs overhaul – Prof. Valery Feigin – New Zealand
09:44 Discussion – Q&A
09:55-10:35 am CEST
Break – Poster Viewing and Oral Presentation (Video on Demand section)
10:35-10:50 am CEST
Plenary session 2: Application of risk prediction (scores) in neurology
Chairs: Prof. Derrick Bennett, PhD Matthew Chun
10:35 Stroke risk prediction using machine learning: a prospective cohort study of 0.5 million Chinese adults – PhD Matthew Chun – UK
10:50-12:00 pm CEST
Plenary session III: Neuroepidemiology of cognition
Chairs: Prof. Anna K. Bonkhoff, Dr. Dearbhla Kelly
10:50 Lesion location helps to better understand cognitive impact of cerebrovascular disease: the Mata VCI Map consortium – Prof. Geert Jan Biessels – Netherlands
11:05 Targeting exercise to prevent vascular cognitive impairment: the Post-Ischaemic Stroke Cardiovascular Exercise Study – Prof. Amy Brodtmann – Australia
11:16 Epidemiology and novel risk factors for dementia after stroke – Prof. Sarah Pendlebury – UK
11:31 Preventing Vascular Cognitive Impairment with multiple lifestyle interventions – Prof. Christopher Chen – Singapore
11:46 Discussion – Q&A
12:00-12:30 pm CEST
Plenary session IV: Genetics and Application of Mendelian Randomisation in neurology
Chairs: Dr. Eric Harshfield, Prof. Suzanna Larsson
12:00 Metabolic associations with ischaemic stroke, dementia, and imaging markers of cerebral small vessel disease: a comprehensive metabolomics study – Dr. Eric Harshfield – UK
12:09 Genetics of stroke in Africans – PhD Rufus Akinyemi – Nigeria
12:26 Discussion – Q&A
12:30-13:20 pm CEST
Break – Poster Viewing and Oral Presentation (Video on Demand section)
13:20-15:15 pm CEST
Plenary session 5: Epidemiology of multiple sclerosis, ALD and demyelinating diseases
Chairs: Prof. Carlos N. Ketzoian, Prof. Fernando Gracia
13:20 Multiple Sclerosis Incidence in Uruguay: A Population-based Study- Prof. Carlos N. Ketzoian – Uruguay
13:36 Barriers to access and utilization of multiple sclerosis care services in Latin American patients – MD Jorge Correale – Argentina
13:57 Poverty and neurological disorders in middle-low income countries – Prof. Carlos N. Ketzoian – Uruguay
14:13 Prevalence and incidence surveys of MS in Latin America and the Caribbean – Prof. Fernando Gracia – Panama
14:31 Environmental factors involved in the development of MS in Latin America – MD Jorge Correale – Argentina
14:59 Discussion – Q&A
15:15-18:06 pm CEST
Special session: Brain Health, One Health and COVID-19
Chairs: Prof. David Wiebers, Prof. Andrea Winkler
15:15 Brain Health, One Health, COVID-19 and Our Collective Future – Prof. David Wiebers – USA
15:34 ‘Brain Health’: vision or study endpoint? – Prof. Michael Brainin – Austria
15:59 Advantages of a One Health Approach For Communicable and Noncommunicable Diseases – Prof. Andrea Winkler – Germany
16:28 One Welfare, the Role of Health Professionals and Climate Change – Dr Anne Quain – Australia
16:49 Harm, Earth Juris Prudence and Human/Nonhuman Relationships – Prof.Tanya Wyatt – UK
17:09 Rethinking Global Governance to Address Zoonotic Disease Risk – Prof. Kelley Lee – Canada
17:36 Discussion – Q&A
Day 2
Thursday
31 March 2022
7:00-8:30 am CEST
Plenary Session 6: Statistical techniques to improve the use of observational data
Chairs: Prof. Dominique Cadilhac, Christian Gunge Riberholt
07:00 Propensity score techniques – Dr. Muideen Olaiya – Australia
07:15 Statistical considerations for reducing the risk of type I or II errors in systematic reviews and meta-analysis – Christian Gunge Riberholt – Denmark
07:29 Target trial approach in comparative effectiveness studies
for stroke – A/Prof. Monique Kilkenny – Australia
07:44 Patient reported outcomes for guiding clinical practice, comparing service performance, and clinical data interpretation – Prof. Dominique Cadilhac – Australia
07:59 Discussion – Q&A
8:30-11:45 am CEST
Plenary session 7: Innovations in epidemiology of neurological disorders in LMIC
Chairs: Prof. Jeyaraj Pandian, Prof. Wenzhi Wang
8:30 Artificial Intelligence in stroke epidemiology – Prof. Jeyaraj Pandian – India
08:45 Epidemiology and community control of epilepsy in rural areas of China – Prof. Wenzhi Wang – China
09:00 Neuropsychological rehabilitation in low resource settings – Challenges and outcomes – Prof. Jagjit S. Chopra – Singapore
09:12 Methodology for documentation of stroke deaths in LMICs: challenges and way forward – Prof. Jeyaraj Pandian – India
09:24 Epidemiology of brain injury – Prof. Dongling Sun – China
09:36 How to integrate stroke implementation research in health care system of developing countries – Prof. Jeyaraj Pandian – India
09:49 Epidemiology of stroke and TIA. – Prof. Siqi Ge – China
10:04 Cognitive and psychological rehabilitation in psychogenic non-epileptic seizures versus generalized epilepsy – Prof. Jagjit S. Chopra – Singapore
10:16 Challenges and Opportunities of neurological research insub-Saharan Africa – Prof. Andrea Winkler – Germany
10:29 Discussion – Q&A
10:30-11:45 am CEST
Break – Poster Viewing and Oral Presentation (Video on Demand section)
11:45-14:15 pm CEST
Scientific session 1: Stroke and dementia
Chairs: Dr Margit Alt Murphy, MD Denis Gabriel
11:45 Upper limb sensorimotor assessment after stroke – recommendations and implementation – Dr Margit Alt Murphy – Sweden
12:04 Cognition, function and prevalent dementia in Centenarians and Near-Centenarians: an individual participant data (IPD) meta-analysis of 18 studies – Prof. Perminder Sachdev – Australia
12:20 MTHFR and risk of stroke, ischemic heart disease and major non-vascular diseases: a Mendelian randomization study of Chinese adults – Prof. Derrick Bennett – UK
12:43 Virtual Reality in stroke rehabilitation – Dr Margit Alt Murphy– Sweden
13:03 Causal associations of blood lipids with risk of ischaemic stroke and intracerebral haemorrhage – Prof. Derrick Bennett – UK
13:24 The burden of stroke in Africa – PhD Rufus Akinyemi – Nigeria
13:42 Long-term prognosis of primary intracerebral haemorrhage in XXI century hospital cohorts compared to populations-based cohorts – MD Denis Gabriel – Portugal
13:53 Discussion – Q&A
14:15-15:30 pm CEST
Scientific session 2: Using research to change stroke policies
Chairs: Prof. Sheila Martins, Prof. Yannick Béjot
14:15 How to use registries and epidemiological data to change policies? – Prof. Sheila Martins – Brazil
14:32 Clinical profile gap between stroke patients included in therapeutic trials and those in real-life practice: an important issue to deal with – Prof. Yannick Béjot – France
14:46 How to translate clinical trials in national policies?- Prof. Octavio Marques Pontes Neto – Brazil
15:01 The gaps and solutions for primary prevention across the globe – to show the gaps and what the countries are doing to improve – Prof. Sheila Martins – Brazil
15:15 Discussion – Q&A
15:30-16:40 pm CEST
Scientific session 3: International networks to advance neurological science & practice
Chairs: Prof. Marian Brady, Prof. Julie Bernhardt
15:30 The Power of Dance for Parkinson’s: Developing Global Networks – Prof. Meg Morris – Australia
15:47 The Collaboration of Aphasia Trialists; standardizing assessments to measure aphasia rehabilitation – Prof. Carolina Mendez Orellana – Chile
15:57 Global Collaboration: Lessons from Multiple Sclerosis – Prof. Robert J Fox – USA
16:08 The International Stroke Recovery & Rehabilitation Alliance – Prof. Geert Verhyeden – Belgium
16:21 Discussion – Q&A
Day 3
Friday
1 April 2022
9:00-11:10 am CEST
Plenary session 8: Cognitive impairment and dementia
Chairs: Prof. Yannick Béjot, Prof. Giancarlo Logroscino
09:00 Stroke in patients with cognitive impairment – Prof. Yannick Béjot – France
09:16 Epidemiology, profile and determinant of post – stroke vascular cognitive impairment – PhD Rufus Akinyemi – Nigeria
09:35 Diagnosis and management of post-stroke cognitive impairment in clinical practice – Prof. Olivier Godefroy – France
09:52 Frontiers: FTD Incidence in Europe – Prof. Giancarlo Logroscino – Italy
10:03 Cerebral small vessel disease in patients with cognitive decline – Prof. Stéphanie Debette – France
10:21 Cognitive Impairment and Hearing Loss – Prof. Giancarlo Logroscino – Italy
10:38 Olfactory dysfunction and cognitive decline among older adults – Prof. Ding Ding – China
10:58 Discussion – Q&A
11:15-13:30 pm CEST
Plenary session 9: epidemiology of neurodegenerative disorders, epilepsy and headaches
Chairs: Prof. Tissa Wijeratne
11:15 Epidemiology of headache disorders in Emergency Department; Global perspectives and unmet need – Prof. Tissa Wijeratne – Australia
11:29 Sudden onset death in epilepsy (SUDEP): Can it be prevented? – Prof. Terence O’Brien – Australia
11:46 Psychotic and Behavioral Symptoms in neurodegenerative diseases – Prof. Giancarlo Logroscino – Italy
12:01 Epidemiology of epilepsy in South East Asian Region – Prof. Jithangi Wanigasinghe – Sri Lanka
12:16 100 million people – the success story of World Brain Day, reflections on global advocacy in neurology – Prof. Tissa Wijeratne – Australia
12:33 Antecedent autoimmune conditions and amyotrophic lateral sclerosis – Dr Jessica Hinman – USA
12:46 New perspectives in research for Alzheimer Disease – Prof. Eduardo Zimmer – Brazil
13:01 Diabetes, Diabetes Medicationsand the Risk of Developing ALS – Prof. Lorene Nelson – USA
13:11 Discussion – Q&A